Pacific Biosciences of California Inc.
PACB | NASDAQ
$1.47
+$0.11 (+8.09%)
Sep 22, 2026, 12:31 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -1.03 | -1.62 | -8.11 | -5.84 | -22.99 | 144.11 |
PEG Ratio | -0.02 | 0.24 | 0.60 | -0.10 | 0.04 | -1.07 |
PS Ratio | 3.51 | 3.26 | 12.41 | 14.32 | 31.92 | 54.31 |
PB Ratio | 104.87 | 0.99 | 3.55 | 3.26 | 5.27 | 12.77 |
P/FCF Ratio | -4.92 | -2.37 | -9.03 | -6.56 | -35.57 | 232.07 |
P/OCF Ratio | -5.04 | -2.44 | -9.33 | -6.98 | -37.47 | 219.71 |
OCF/S Ratio | -69.50 | -133.79 | -132.93 | -205.15 | -85.19 | 24.72 |
Debt / Equity Ratio | 141.98 | 1.33 | 1.33 | 1.68 | 1.21 | 0.13 |
Quick Ratio | 5.99 | 6.59 | 7.21 | 3.04 | 15.01 | 8.87 |
Current Ratio | 6.89 | 7.48 | 7.81 | 3.24 | 15.36 | 9.24 |
Asset Turnover | 0.20 | 0.12 | 0.11 | 0.07 | 0.07 | 0.19 |
Interest Coverage | -80.18 | -35.36 | -23.32 | -20.91 | -16.79 | -390.96 |
Return on Equity | -10.21K% | -61.16% | -43.74% | -55.83% | -22.91% | 8.76% |
Return on Assets | -69.68% | -24.58% | -17.57% | -17.78% | -9.03% | 7.10% |
Return on Invested Capital | -76.32% | -39.39% | -19.41% | -20.28% | -7.13% | -27.48% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 31.67% | 24.21% | 26.32% | 38.22% | 45.10% | 41.28% |
Net Profit Margin | -341.47% | -201.18% | -152.97% | -244.92% | -138.85% | 37.27% |
Pretax Profit Margin | -341.28% | -200.98% | -158.67% | -244.92% | -210.61% | 37.27% |
Operating Profit Margin | -348.46% | -307.97% | -166.80% | -239.43% | -161.24% | -132.31% |
FCF Margin | -71.20% | -137.81% | -137.34% | -218.34% | -89.73% | 23.40% |
EBITDA Margin | -21.37% | -157.63% | -135.21% | -219.98% | -192.13% | 49.40% |
Add to Watchlist
Select watchlists to add or remove PACB